Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-676812
Filing Date
2016-08-09
Accepted
2016-08-09 16:27:12
Documents
83
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d164971d10q.htm 10-Q 568919
2 EX-31.1 d164971dex311.htm EX-31.1 9004
3 EX-31.2 d164971dex312.htm EX-31.2 9044
4 EX-32.1 d164971dex321.htm EX-32.1 4246
5 EX-32.2 d164971dex322.htm EX-32.2 4058
12 GRAPHIC g164971g103625g42y81.jpg GRAPHIC 26397
  Complete submission text file 0001193125-16-676812.txt   5220331

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mslp-20160630.xml EX-101.INS 776463
7 XBRL TAXONOMY EXTENSION SCHEMA mslp-20160630.xsd EX-101.SCH 70666
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mslp-20160630_cal.xml EX-101.CAL 106526
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mslp-20160630_def.xml EX-101.DEF 303158
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mslp-20160630_lab.xml EX-101.LAB 574642
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mslp-20160630_pre.xml EX-101.PRE 433090
Mailing Address 4721 IRONTON STREET DENVER CO 80239
Business Address 4721 IRONTON STREET DENVER CO 80239 (800) 210-7369
MusclePharm Corp (Filer) CIK: 0001415684 (see all company filings)

EIN.: 770664193 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53166 | Film No.: 161818315
SIC: 2834 Pharmaceutical Preparations